News & Events

Date:
Oct 27, 2022

Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling

New Article published in Nature Cancer - Amit Lab

READ MORE about Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling
Date:
Sep 29, 2022

Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions

New Article published in Cell - StraussmanLab

READ MORE about Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Date:
Sep 1, 2022

Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance

New Article published in Cell - Elinav Lab

READ MORE about Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance
Date:
Aug 4, 2022

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

New Article published in Cell - Elinav Lab

Sara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas,Denise Kviatcovsky, et al.

READ MORE about Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation
Date:
May 25, 2022

Generation of specialized blood vessels via lymphatic transdifferentiation

New Article published in Nature - Yaniv Lab

READ MORE about Generation of specialized blood vessels via lymphatic transdifferentiation
Date:
May 18, 2022

Visual barcodes for clonal-multiplexing of live microscopy-based assays

New Article published in Nature Communications - Straussman Lab

READ MORE about Visual barcodes for clonal-multiplexing of live microscopy-based assays
Date:
Mar 31, 2022

Tumor-reactive antibodies evolve from non-binding and autoreactive precursors

New Article published in Cell - Shulman Lab

Roei D. Mazor, Nachum Nathan, Amit Gilboa, et al.

READ MORE about Tumor-reactive antibodies evolve from non-binding and autoreactive precursors
Date:
Mar 23, 2022

Antibodies Fight Cancer Too

Shulman Lab

READ MORE about Antibodies Fight Cancer Too
Date:
Mar 8, 2022

Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation

New Article published in Immunity - Shulman Lab

READ MORE about Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation
Date:
Feb 18, 2022

A Matter of Survival: How the Immune System Sets Priorities

Shulman Lab

READ MORE about A Matter of Survival: How the Immune System Sets Priorities

News & Events

Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling

Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions

Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

Generation of specialized blood vessels via lymphatic transdifferentiation

Visual barcodes for clonal-multiplexing of live microscopy-based assays

Tumor-reactive antibodies evolve from non-binding and autoreactive precursors

Antibodies Fight Cancer Too

Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation

A Matter of Survival: How the Immune System Sets Priorities